Targeting caspases in cancer therapeutics P Hensley, M Mishra, N Kyprianou Biological chemistry 394 (7), 831-843, 2013 | 180 | 2013 |
Hesperidin and silibinin ameliorate aluminum-induced neurotoxicity: modulation of antioxidants and inflammatory cytokines level in mice hippocampus A Jangra, P Kasbe, SN Pandey, S Dwivedi, SS Gurjar, M Kwatra, ... Biological trace element research 168, 462-471, 2015 | 113 | 2015 |
Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats M Kwatra, V Kumar, A Jangra, M Mishra, S Ahmed, P Ghosh, D Vohora, ... Pharmaceutical biology 54 (4), 637-647, 2016 | 96 | 2016 |
Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy H Jiang, L Wu, M Mishra, HA Chawsheen, Q Wei American journal of cancer research 4 (5), 445, 2014 | 87 | 2014 |
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases CA Artusi, M Mishra, P Latimer, JA Vizcarra, L Lopiano, W Maetzler, ... Parkinsonism & related disorders 46, S53-S56, 2018 | 85 | 2018 |
The Sulfiredoxin-Peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development M Mishra, H Jiang, L Wu, HA Chawsheen, Q Wei Cancer letters 366 (2), 150-9, 2015 | 85 | 2015 |
Naringin and sertraline ameliorate doxorubicin-induced behavioral deficits through modulation of serotonin level and mitochondrial complexes protection pathway in rat hippocampus M Kwatra, A Jangra, M Mishra, Y Sharma, S Ahmed, P Ghosh, V Kumar, ... Neurochemical research 41, 2352-2366, 2016 | 66 | 2016 |
Sulfiredoxin promotes colorectal cancer cell invasion and metastasis through a novel mechanism of enhancing EGFR signaling H Jiang, L Wu, J Chen, M Mishra, HA Chawsheen, H Zhu, Q Wei Molecular Cancer Research 13 (12), 1554-1566, 2015 | 41 | 2015 |
Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis L Wu, H Jiang, HA Chawsheen, M Mishra, MR Young, M Gerard, ... Carcinogenesis 35 (5), 1177-1184, 2014 | 31 | 2014 |
When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis L Marsili, JA Vizcarra, A Sturchio, AK Dwivedi, EG Keeling, D Patel, ... Journal of Neurology 268, 3203-3211, 2021 | 17 | 2021 |
Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis M Mishra, H Jiang, HA Chawsheen, M Gerard, MB Toledano, Q Wei Cancer letters 432, 216-226, 2018 | 15 | 2018 |
New insights on the differential interaction of sulfiredoxin with members of the peroxiredoxin family revealed by protein-protein docking and experimental studies M Mishra, H Jiang, Q Wei European Journal of Pharmacology 954, 175873, 2023 | 2 | 2023 |
The clinical characteristics of childhood-onset and late-onset functional seizures: How do they differ? AA Asadi-Pooya, M Mishra, M Farazdaghi, J Fox Epilepsy & Behavior 145, 109336, 2023 | 2 | 2023 |
PRDX4 (peroxiredoxin 4) M Mishra, HA Chawsheen, L Wu, H Jiang, Q Wei http://AtlasGeneticsOncology. org, 709, 2013 | 1 | 2013 |
Neuropsychological characteristics of drug resistant epilepsy patients with and without comorbid functional seizures J Fox, MK Bollig, M Mishra, M Jacobs Epilepsy Research, 107340, 2024 | | 2024 |
Hypertension and other vascular risk factors in patients with functional seizures J Fox, M Mishra Epilepsy & Behavior 152, 109650, 2024 | | 2024 |
Reader Response: Sex Differences in Clinical Features, Treatment, and Lifestyle Factors in Patients With Cluster Headache M Mishra | | 2023 |
Reader response: Sleep duration, midday napping, and sleep quality and incident stroke: The Dongfeng-Tongji cohort M Mishra | | 2022 |
Reporting non-binary genders in medical records: Should we make gender reporting more dynamic? M Mishra Ethics, Medicine and Public Health 24, 100844, 2022 | | 2022 |
An Opportunity in the Realm of Off-Target Effects M Mishra EC PHARMACOLOGY AND TOXICOLOGY 5 (3), 134-140, 2018 | | 2018 |